RMTI
Rockwell Medical, Inc.
RMTI's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over RMTI overall, supported by lower modeled downside and stronger modeled upside.
RMTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
RMTI's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
RMTI PE Valuation
RMTI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
RMTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect RMTI's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
RMTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.43 | +$0.17 |
| Q2 2026 | -$1.34 | -$0.64 |
| Q1 2026 | -$1.50 | -$1.40 |
| Q4 2025 | -$1.50 | -$1.20 |
| Q3 2025 | -$1.60 | -$1.16 |
| Q2 2025 | -$0.70 | +$0.84 |
| Q1 2025 | -$0.10 | +$3.34 |
| Q4 2024 | -$0.30 | +$3.54 |
RMTI is still losing money, but far less than before: $1.43 per share over the past year, against $61.60 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over RMTI on earnings quality, reporting a profit while its opponent remains loss making.
RMTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +20% |
| Q2 2026 | $17.8M | +11% |
| Q1 2026 | $17.3M | -8.3% |
| Q4 2025 | $18.3M | -26% |
| Q3 2025 | $15.9M | -44% |
| Q2 2025 | $16.1M | -38% |
| Q1 2025 | $18.9M | -17% |
| Q4 2024 | $24.7M | +12% |
RMTI's revenue is recovering but still below its 2024 peak: $19M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -1.7 points |
| Q2 2026 | -6% | +2.4 points |
| Q1 2026 | -8.5% | -1.3 points |
| Q4 2025 | -2.2% | -0.1 points |
| Q3 2025 | -10% | -17 points |
| Q2 2025 | -8.4% | -10 points |
| Q1 2025 | -7.2% | -1.4 points |
| Q4 2024 | -2.1% | +0.4 points |
RMTI's operating margin was −12% last quarter, down 1.7 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over RMTI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over RMTI on profitability, with a higher operating margin.
RMTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.2M | -$712K |
| Q2 2026 | $1.5M | -13% |
| Q1 2026 | -$592K | +$3M |
| Q4 2025 | $2.2M | +369% |
| Q2 2025 | $1.7M | +17% |
| Q1 2025 | -$3.6M | -$1.2M |
| Q4 2024 | $470K | +$513K |
| Q2 2024 | $1.4M | +$3.2M |
RMTI has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
RMTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +13.4K shares |
| 1 year | +10% | +369K shares |
| 3 years | +115% | +2.1M shares |
| 5 years | +367% | +3.1M shares |
| Available history | +617% | +3.4M shares |
RMTI has 4M diluted shares, up 10% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over RMTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
RMTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -4.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -2.6x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
RMTI has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
RMTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.4 | Neutral |
| Stochastic | 34.5 | Neutral |
RMTI's weekly RSI is 46 (neutral) and its Stochastic is 34 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
RMTI PE vs Healthcare Sector
RMTI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
RMTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.68 | 3.9% below |
| 20 week MA | $7.37 | 0.1% above |
| 50 week MA | $8.25 | 11% below |
| 100 week MA | $10.8 | 32% below |
| 200 week MA | $17.0 | 57% below |
RMTI's trend is mixed: it's above one of its five weekly moving averages, and 57% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over RMTI on trend strength, trading above more of its moving averages.
RMTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $258.5 | $111.1 | -57% |
| 2021 | $111.1 | $44.0 | -60% |
| 2022 | $44.0 | $9.70 | -78% |
| 2023 | $9.70 | $18.9 | +95% |
| 2024 | $18.9 | $21.4 | +13% |
| 2025 | $21.4 | $8.65 | -60% |
| 2026 YTD | $8.65 | $7.38 | -15% |
RMTI has finished lower in four of the last six years. It's down 15% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over RMTI on returns for 2026, with the stronger performance.